Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,801
datasets available to search
ShareScore release 0.7.1
Dataset results
2,801 results for “diabetes mellitus”
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT02367066. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
ClinicalTrials.gov study NCT02910089. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02453555. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02420262. IPD Sharing: Not stated. Countries: 12. Publications: 3.
A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03596177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT02803918. IPD Sharing: YES. Countries: 6. Publications: 1.
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02597049. IPD Sharing: YES. Countries: 9. Publications: 2.
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
ClinicalTrials.gov study NCT00308139. IPD Sharing: Not stated. Countries: 2. Publications: 10.
STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
ClinicalTrials.gov study NCT04616027. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01792284. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01807221. IPD Sharing: Not stated. Countries: 25. Publications: 4.
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00700817. IPD Sharing: Not stated. Countries: 15. Publications: 14.
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT00328627. IPD Sharing: Not stated. Countries: 19. Publications: 1.
The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired
ClinicalTrials.gov study NCT03152084. IPD Sharing: YES. Countries: 2. Publications: 2.
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
ClinicalTrials.gov study NCT01105858. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
ClinicalTrials.gov study NCT01126580. IPD Sharing: Not stated. Countries: 19. Publications: 4.
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
ClinicalTrials.gov study NCT02025907. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02302716. IPD Sharing: YES. Countries: 7. Publications: 2.
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
ClinicalTrials.gov study NCT02414958. IPD Sharing: Not stated. Countries: 17. Publications: 2.
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01370005. IPD Sharing: YES. Countries: 12. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.